SUPRIYA

SUPRIYA LIFESCIENCE

Small Cap BSE: 543434 NSE: SUPRIYA
₹298.00
1.65 (0.56%)
As on 30 September, 2022 | 02:48

Supriya Lifescience Share Price

Supriya Lifescience Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SUPRIYA LIFESCIENCE

Start SIP

Supriya Lifescience Share Returns

  • Over 1 Month -16.71%
  • Over 3 Month -15.77%
  • Over 6 Month -37.64%
  • Over 1 Year

Supriya Lifescience Key Statistics

P/E Ratio 14.2
PEG Ratio
Market Cap Cr 2,398
Price to Book Ratio 3.9
EPS 18.9
Dividend 0.2
Relative Strength Index 20.9
Money Flow Index 24.69
MACD Signal -8.49
Average True Range 13.11

Supriya Lifescience Investment Rating

  • Master Rating:
  • Supriya Lifescience has an operating revenue of Rs. 547.63 Cr. on a trailing 12-month basis. An annual revenue growth of 36% is outstanding, Pre-tax margin of 39% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 4 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 169 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Supriya Lifescience Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 10118111714884132
Operating Expenses Qtr Cr 7010679706165
Operating Profit Qtr Cr 317538782267
Depreciation Qtr Cr 333222
Interest Qtr Cr 111111
Tax Qtr Cr 529020617
Net Profit Qtr Cr 25464058849

Supriya Lifescience Technicals

EMA & SMA

Current Price
298.
1.65 (0.56%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 332.34
  • 50 Day
  • 346.73
  • 100 Day
  • 365.34
  • 200 Day
  • 20 Day
  • 336.09
  • 50 Day
  • 354.52
  • 100 Day
  • 351.92
  • 200 Day

Supriya Lifescience Resistance and Support

PIVOT
₹302.37
Resistance
First Resistance 310.74
Second Resistance 325.12
Third Resistance 333.49
RSI 20.9
MFI 24.69
MACD Single Line -8.49
MACD -12.5
Support
First Resistance 287.99
Second Resistance 279.62
Third Resistance 265.24

Supriya Lifescience Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 664,639 20,869,665 31.4
Week 475,432 19,430,906 40.87
1 Month 290,936 13,129,920 45.13
6 Month 368,010 14,904,406 40.5

Supriya Lifescience Result Highlights

Supriya Lifescience Synopsis

NSE-Medical-Supplies

Supriya Lifescience is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 530.05 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2022. Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452.
Market Cap 2,398
Sales 548
Shares in Float 2.58
No of funds 24
Yield 0.2
Book Value 3.9
U/D Vol ratio 0.6
LTDebt / Equity
Alpha -0.08
Beta 1.36

Supriya Lifescience

Owner NameJun-22Mar-22Dec-21
Promoters 68.24%68.24%68.24%
Mutual Funds 3.12%3.34%3.34%
Insurance Companies 4.15%1.39%1.43%
Foreign Portfolio Investors 5.99%7.13%10.3%
Financial Institutions/ Banks 0.43%
Individual Investors 12.52%12.73%8.25%
Others 5.98%7.17%8.01%

Supriya Lifescience Management

Name Designation
Mr. Satish Waman Wagh Chairman & Managing Director
Ms. Smita Satish Wagh Whole Time Director
Ms. Saloni Satish Wagh Whole Time Director
Ms. Shivani Satish Wagh Whole Time Director
Mr. Balasahab Gulabrao Sawant Whole Time Director
Mr. Kedar Shankar Karmarkar Independent Director
Mr. Bhairav Manojbhai Chokshi Independent Director
Mr. Dileep Kumar Jain Independent Director
Mr. Dinesh Navnitlal Modi Independent Director
Ms. Neelam Yashpal Arora Independent Director

Supriya Lifescience Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Supriya Lifescience Corporate Action

Date Purpose Remarks
2022-08-12 Quarterly Results
2022-05-20 Audited Results & Final Dividend
2022-01-21 Quarterly Results

Supriya Lifescience MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 21655
Shriram Hybrid Equity Fund Regular Growth 60
Motilal Oswal S&P BSE Healthcare ETF 6

Supriya Lifescience FAQs

What is Share Price of Supriya Lifescience ?

Supriya Lifescience share price is ₹298 As on 30 September, 2022 | 02:34

What is the Market Cap of Supriya Lifescience ?

The Market Cap of Supriya Lifescience is ₹2398.4 Cr As on 30 September, 2022 | 02:34

What is the P/E ratio of Supriya Lifescience ?

The P/E ratio of Supriya Lifescience is 14.2 As on 30 September, 2022 | 02:34

What is the PB ratio of Supriya Lifescience ?

The PB ratio of Supriya Lifescience is 3.9 As on 30 September, 2022 | 02:34

Q1FY23